TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Urologix AB
Closing information (x1000 DKK)
| Closing information | 2024/08 | 2023/08 | 2022/08 |
| Turnover |
4,577
|
4,375
|
5,306 |
| Financial expenses |
3
|
0
|
0 |
| Earnings before taxes |
1,352
|
1,065
|
1,402 |
| EBITDA |
1,444
|
1,147
|
1,429 |
| Total assets |
1,754
|
1,324
|
1,664 |
| Current assets |
689
|
772
|
1,512 |
| Current liabilities |
326
|
325
|
400 |
| Equity capital |
1,428
|
999
|
1,264 |
| - share capital |
66
|
63
|
70 |
| Employees (average) |
4
|
5
|
5 |
Financial ratios
| Fiscal year | 2024/08 | 2023/08 | 2022/08 |
| Solvency |
81.4%
|
75.5%
|
76.0% |
| Turnover per employee |
1,144
|
875
|
1,061 |
| Profit as a percentage of turnover |
29.5%
|
24.3%
|
26.4% |
| Return on assets (ROA) |
77.3%
|
80.4%
|
84.3% |
| Current ratio |
211.3%
|
237.5%
|
378.0% |
| Return on equity (ROE) |
94.7%
|
106.6%
|
110.9% |
| Change turnover |
3
|
-421
|
358 |
| Change turnover % |
0%
|
-9%
|
7% |
| Chg. No. of employees |
-1
|
0
|
0 |
| Chg. No. of employees % |
-20%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/08 | 2023/08 | 2022/08 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.